CSIMarket
 


Exact Sciences Corporation  (EXAS)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Exact Sciences Accounts Receivables Turnover Ratio from the forth quarter 2023 to the forth quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Exact Sciences Corporation's ability to collect accounts receivable sequentially worsen to 13.25, indicating more challenging environment then in the third quarter 2023, but still, it is a far cry from any concerns. Exact Sciences's Average receivable collection period in the Dec 31 2023 quarter, has increased to 28 days, from 27 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 79 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 711, from overall ranking in the third quarter 2023 at 861.

What is Receivable Turnover Ratio?
What is Exact Sciences Corporation Selling?


What is Receivable Turnover Ratio?




EXAS Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Receivable Change 28.84 % 5.39 % -4.41 % -10.82 % -27.05 %
Y / Y Revenue Change 22.81 % 22.53 % 21.05 % 24.3 % 14.53 %
Receivable Turnover Ratio (TTM) 13.25 13.39 12.93 12.17 11.17
EXAS's Total Ranking # 711 # 861 # 938 # 935 # 1023
Average receivable collection period 28 27 28 30 33
Seq. Receivable Change 2.12 % 11.83 % -2.76 % 16.03 % -16.47 %
Seq. Revenue Change 6.63 % 0.56 % 3.98 % 10.15 % 6.39 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 8
Healthcare Sector # 80
Overall Market # 711

Receivable Turnover Ratio Statistics
High Average Low
0.59 0.36 0.02
(Sep 30 2017)   (March 31, 2014)






Financial Statements
Exact Sciences's Accounts Receivable $ 204 Millions Visit EXAS's Balance sheet
Exact Sciences's Sales TTM $ 2,532 Millions Visit EXAS's Income Statement
Where are EXAS's Sales coming from? Visit EXAS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EXAS's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for EXAS's Competitors
Receivables Turnover Ratio for EXAS's Suppliers
Accounts Receivables Turnover Ratio for EXAS's Customers

You may also want to know
EXAS's Growth Rates EXAS's Roa EXAS's Inventory Turnover Ratio EXAS's Dividend Comparisons
EXAS's Profitability Ratios EXAS's Roi EXAS's Asset Turnover Ratio EXAS's Dividend Growth
EXAS's Valuation Ratios EXAS's Roe EXAS's Financial Strength Ratios EXAS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Prothena Corporation Public Limited Company  33.71 $ 91.370  Millions$ 2.711  Millions
National Vision Holdings Inc   26.38 $ 2,126.468  Millions$ 80.611  Millions
Inmed Pharmaceuticals Inc   25.66 $ 6.218  Millions$ 0.242  Millions
Orchestra Biomed Holdings Inc   25.56 $ 2.760  Millions$ 0.108  Millions
Editas Medicine Inc   20.64 $ 78.123  Millions$ 3.784  Millions
Cue Health Inc   20.01 $ 70.936  Millions$ 3.545  Millions
Innovage Holding Corp   19.58 $ 720.796  Millions$ 36.806  Millions
Kiniksa Pharmaceuticals ltd   19.17 $ 270.259  Millions$ 14.095  Millions
Neptune Wellness Solutions Inc   18.45 $ 39.115  Millions$ 2.120  Millions
Valneva Se  18.11 $ 172.159  Millions$ 9.509  Millions
Ensysce Biosciences Inc   17.55 $ 3.385  Millions$ 0.193  Millions
Biofrontera Inc   17.48 $ 116.349  Millions$ 6.657  Millions
Halozyme Therapeutics Inc   17.02 $ 829.253  Millions$ 48.721  Millions
Recursion Pharmaceuticals Inc   15.69 $ 44.575  Millions$ 2.842  Millions
Owens and Minor inc  15.24 $ 10,333.161  Millions$ 677.813  Millions
Neuroone Medical Technologies Corporation  14.87 $ 2.816  Millions$ 0.189  Millions
Chemed Corporation  14.52 $ 2,264.417  Millions$ 155.918  Millions
Icu Medical Inc  14.46 $ 2,259.126  Millions$ 156.262  Millions
Patterson Companies Inc   14.11 $ 6,565.239  Millions$ 465.318  Millions
Corcept Therapeutics Inc  13.70 $ 482.375  Millions$ 35.215  Millions
Theralink Technologies Inc   13.67 $ 0.511  Millions$ 0.037  Millions
Protalix Biotherapeutics inc   13.39 $ 65.494  Millions$ 4.890  Millions
Exact Sciences Corporation  13.25 $ 2,532.479  Millions$ 191.179  Millions
Utah Medical Products Inc  12.39 $ 50.658  Millions$ 4.088  Millions
Teladoc Health Inc   12.18 $ 2,602.415  Millions$ 213.613  Millions
Caribou Biosciences Inc   12.12 $ 34.477  Millions$ 2.844  Millions
Siga Technologies Inc  11.78 $ 139.917  Millions$ 11.881  Millions
Integrated Biopharma Inc  11.42 $ 48.833  Millions$ 4.275  Millions
Option Care Health Inc   11.09 $ 4,302.223  Millions$ 388.081  Millions
National Research Corporation  11.05 $ 148.580  Millions$ 13.445  Millions

Date modified: 2024-02-22T09:21:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com